0
Skip to Content
PAREA
PAREA
Home
About
About
Members
Meet the Team
Learn
Why
FAQs
Governance
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
MEP Action Group
About
Members
Events
Latest
News
Events
Videos
Support Us
PAREA
PAREA
Home
About
About
Members
Meet the Team
Learn
Why
FAQs
Governance
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
MEP Action Group
About
Members
Events
Latest
News
Events
Videos
Support Us
Home
Folder: About
Back
About
Members
Meet the Team
Folder: Learn
Back
Why
FAQs
Folder: Governance
Back
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
Folder: MEP Action Group
Back
About
Members
Events
Folder: Latest
Back
News
Events
Videos
Support Us
16/06/2025

Presentation of the results of ketamine-assisted therapy program for treatment resistant depression

Next

Testimonial of Andrea Siclari, cancer patient, delivered at the EU Parliament event on 06.02.2025

You Might Also Like

Related Embedded Video Item Thumbnail Dave Pounds - MDMA for Alcohol Use Disorder
Related Embedded Video Item Thumbnail Maryam Jabir - challenging, unresolved psychedelic experience: psilocybin therapy for treatment resistant depression
Related Embedded Video Item Thumbnail Advancing Psychedelic Policy in Europe by Tadeusz Hawrot at ALPS Conference 2023
Related Embedded Video Item Thumbnail Launch of the PsychedeliCare and MEP Action Group on Psychedelics in Healthcare at the European Parliament 06.02.2025
Related Embedded Video Item Thumbnail SA TAIP seminar | Tadeusz Hawrot - "Psychedelic advances in the EU"

Contact

tadeusz@parea.eu

Our Work

About
Why

© Parea 2024 | Privacy Policy